Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
Sponsor: Novartis Pharmaceuticals
Chronic Myelogenous Leukemia
United States, Argentina, Australia, Brazil, Bulgaria +20 more
Sponsor: AstraZeneca
Non-small Cell Lung Cancer
United States, Brazil, Canada, Hong Kong, Japan +5 more
- A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab AloneActive Not Recruiting
Sponsor: Boehringer Ingelheim
Head and Neck Squamous Cell Carcinoma
United States, Australia, Brazil, Bulgaria, France +17 more
Sponsor: Biogen
Muscular Atrophy, Spinal
United States, Australia, Brazil, China, Japan
- A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).Active Not Recruiting
Sponsor: Cytokinetics
Pediatric · Symptomatic Obstructive Hypertrophic Cardiomyopathy
United States, Canada, Italy, Japan, Spain +1 more
- A Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement InhibitorsActive Not Recruiting
Sponsor: Hoffmann-La Roche
Paroxysmal Nocturnal Hemoglobinuria
Argentina, Brazil, China, France, Germany +18 more
- A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque PsoriasisCompleted
Sponsor: DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
Plaque Psoriasis
United States, Canada, Czechia, Germany, Hungary +2 more
- Product Surveillance RegistryRecruiting
Sponsor: Medtronic
Cardiac Rhythm Disorders · Urological Disorders · Neurological Disorders · Cardiovascular Disorders
United States, Argentina, Australia, Austria, Belgium +36 more
Sponsor: Daiichi Sankyo
HER2-positive Gastric Cancer · HER2-positive Gastroesophageal Junction
China
Sponsor: Pfizer
Small Cell Lung Cancer · Small Cell Lung Cancer ( SCLC ) · Transformed Small Cell Lung Cancer · Lung Neoplasms
United States, Brazil, China, France, Hong Kong +5 more
Sponsor: Pfizer
Atopic Dermatitis
United States, China, Germany, Hungary, Japan +3 more
Sponsor: Pfizer
Urothelial Cancer · Advanced/Metastatic Urothelial Cancer · Urothelial Carcinoma
United States, Australia, China, Japan, Puerto Rico +1 more
Sponsor: Pfizer
Advanced Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung (NSCLC)
United States, Argentina, Australia, Brazil, Canada +15 more
- A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)Recruiting
Sponsor: Merck Sharp & Dohme LLC
Lipoprotein(a)
United States, Japan
- A Study to Learn About the Study Medicine - Zavicefta in Patients With Sepsis or Loss of Kidney Function in JapanActive Not Recruiting
Sponsor: Pfizer
Infectious Diseases
Japan
- Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPCActive Not Recruiting
Sponsor: Pfizer
mCRPC
United States, Argentina, Australia, Belgium, Brazil +21 more
Sponsor: Generate Biomedicines
Severe Asthma
United States, Argentina, Australia, Belgium, France +6 more
- A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.Active Not Recruiting
Sponsor: Sanofi
Relapsing Multiple Sclerosis · Secondary Progressive Multiple Sclerosis · Progressive Relapsing Multiple Sclerosis
United States, Argentina, Australia, Austria, Belgium +42 more
Sponsor: AstraZeneca
Gastroesophageal Adenocarcinoma
United States, Canada, China, Georgia, Italy +6 more
Sponsor: Bristol-Myers Squibb
Non-small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +26 more
Sponsor: Pfizer
Intestinal Neoplasms · Gastrointestinal Neoplasms · Digestive System Neoplasms · Neoplasms by Site
United States, Argentina, Australia, Belgium, Brazil +12 more
Sponsor: Pfizer
Obesity · Overweight and/or Obesity · Overweight
United States, Brazil, Canada, Japan
- A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLCActive Not Recruiting
Sponsor: Amgen
Small Cell Lung Cancer (SCLC)
United States, Argentina, Australia, Belgium, Brazil +11 more
- A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative ColitisActive Not Recruiting
Sponsor: Takeda
Ulcerative Colitis
United States, Australia, Belgium, Bulgaria, Canada +17 more
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Small-cell Lung Cancer
United States, Austria, Belgium, China, France +8 more